Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005 for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT07605637 is registered in ClinicalTrials.gov with Beijing GoBroad Hospital as lead sponsor.

NCT NCT07605637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005 for the Treatment of Relapsed/Refractory Autoimmune Diseases
Lead sponsor
Beijing GoBroad Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
November 30, 2027
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory autoimmune diseases